Cita APA

Makowski, K., Vigevani, L., Albericio, F., Valcárcel, J. (., & Álvarez, M. (2017). Sudemycin K: A synthetic antitumor splicing inhibitor variant with improved activity and versatile chemistry.

Citación estilo Chicago

Makowski, Kamil, Luisa Vigevani, Fernando Albericio, J. (Juan) Valcárcel, y Mercedes Álvarez. Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant With Improved Activity and Versatile Chemistry. 2017.

Cita MLA

Makowski, Kamil, et al. Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant With Improved Activity and Versatile Chemistry. 2017.